John Crowley, Biotechnology Innovation Organization (BIO) president and CEO, joins 'Squawk Box' to discuss 50 years of ...

A CEO at a Chicago biotech company is sharing words of encouragement while making lives better through her research. For Women's History Month, meet Ritu Shah. Among the labs at a biotech facility in ...

The private placement includes about $180 million upfront and $174 million if the company gets FDA approval for its ...

Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corporate Development REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (NASDAQ/TASE ...

Focused on infectious disease therapies, this biotech firm reported a notable insider sale amid a year of strong share price ...

"Countries no longer compete on the basis of low-cost labor; they compete on brain power,” says Biogen CEO Chris Viehbacher ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.

Flagship Pioneering-backed Alltrna is once again laying off staff, this time reducing its workforce by 19 people. The decision was made to “position Alltrna for success as we accelerate toward the ...

A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine contamination problems — before those issues were made public, according to a ...

Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Cannara Biotech Inc. (LOVE:CA) (OTCQX: LOVFF) (FSE: 8CB0) is a vertically integrated producer of affordable premium-grade cannabis and ...

REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (PPBT), a clinical-stage company developing next-generation cancer therapies, today announced that Gil Efron, Chief Executive ...